Inventor · disambiguated record
Markus Rudolph
Also filed as: RUDOLPH MARKUS
32 granted patents·9 pending applications·125 citations·filing 2009–2023
96Inventor score
Files withHOFFMANN LA ROCHE34ALBERATI DANIELA3BENSON GREGORY MARTIN2ALVAREZ SANCHEZ RUBEN1BACHMANN STEPHAN1
Top patents by PatentIndex Score
41 records- 0197US9802944B2Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Oct 31, 2017·20 cites·23 claims
- 0295US10654857B2Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted May 19, 2020·10 cites·27 claims
- 0395US10640472B2Phenoxymethyl derivativesHOFFMANN LA ROCHE·Filed 2018·Granted May 5, 2020·10 cites·23 claims
- 0494US10669285B2Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Jun 2, 2020·9 cites·26 claims
- 0593US10889588B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jan 12, 2021·3 cites·23 claims
- 0693US10647719B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted May 12, 2020·10 cites·36 claims
- 0791US11098048B2Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 24, 2021·2 cites·17 claims
- 0891US10800786B2Bicyclic compounds as ATX inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Oct 13, 2020·4 cites·31 claims
- 0990US10738053B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Aug 11, 2020·5 cites·23 claims
- 1089US10787459B2Bicyclic compounds as ATX inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Sep 29, 2020·4 cites·23 claims
- 1188US10849881B2Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-ylHOFFMANN LA ROCHE·Filed 2018·Granted Dec 1, 2020·3 cites·20 claims
- 1287US10882857B2Bicyclic compounds as ATX inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jan 5, 2021·3 cites·30 claims
- 1387US8178538B2PyridazinonesALBERATI DANIELA·Filed 2009·Granted May 15, 2012·16 cites·50 claims
- 1483US9394311B2Triazolo compounds as PDE10 inhibitorsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 19, 2016·7 cites·9 claims
- 1582US11352330B2Phenoxymethyl derivativesHOFFMANN LA ROCHE·Filed 2020·Granted Jun 7, 2022·1 cites·10 claims
- 1680US11059794B2Heterocyclic compounds useful as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jul 13, 2021·2 cites·35 claims
- 1777US8263584B2ImidazopyridinesALBERATI DANIELA·Filed 2011·Granted Sep 11, 2012·4 cites·18 claims
- 1876US8017604B2ImidazopyridinesHOFFMANN LA ROCHE·Filed 2010·Granted Sep 13, 2011·3 cites·29 claims
- 1974US9199938B2Aryl-quinoline derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Dec 1, 2015·2 cites·16 claims
- 2074US8772510B2PDE10 modulatorsBACHMANN STEPHAN·Filed 2012·Granted Jul 8, 2014·3 cites·25 claims
- 2170US8410117B2Imidazopyrimidine derivativesALVAREZ SANCHEZ RUBEN·Filed 2011·Granted Apr 2, 2013·4 cites·26 claims
- 2266US11673888B2Bicyclic compounds as ATX inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jun 13, 2023·0 cites·12 claims
- 2365US2021015792A1OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YLHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2462US2018111941A1Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitorsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2559US2023234939A1Imidazole-pyrazole derivatives as antibacterialsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2659US2020199155A1Condensed [1,4] diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2759US2020223854A1Bicyclic compounds as dual atx/ca inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2858US2025388536A13-alkynyl carboxamides as aep modulatorsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2955US2018208602A1New bicyclic compounds as atx inhibitorsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3052US10435407B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Oct 8, 2019·0 cites·23 claims
- 3151US8153663B23-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivativesBENSON GREGORY MARTIN·Filed 2009·Granted Apr 10, 2012·0 cites·20 claims
- 3250US2016264586A1OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YLHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3349US10239876B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Mar 26, 2019·0 cites·25 claims
- 3449US2018312515A1New bicyclic compounds as atx inhibitorsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3547US11001555B2Difluoroketamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted May 11, 2021·0 cites·31 claims
- 3645US10870623B2Trifluoromethylpropanamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 22, 2020·0 cites·28 claims
- 3745US10865182B2Difluoroketamide derivatives as HtrA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 15, 2020·0 cites·28 claims
- 3844US9809599B2Aryl-quinoline derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Nov 7, 2017·0 cites·26 claims
- 3936US8309581B2Benzimidazole derivativesBENSON GREGORY MARTIN·Filed 2010·Granted Nov 13, 2012·0 cites·13 claims
- 4034US9187455B2Substituted pyridazines as PDE10A inhibitorsALBERATI DANIELA·Filed 2010·Granted Nov 17, 2015·0 cites·24 claims
- 4133US9656971B2COMT inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted May 23, 2017·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Markus Rudolph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →